Puma Biotechnology says its breast cancer therapy included in two key NCCN updates | Seeking Alpha
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Puma Bio Stock: Still Worthy After Earnings Surprise (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2022 Earnings Call Transcript
Puma Biotechnology Third Quarter 2022 Earnings: Beats Expectations
Puma Biotechnology Reports Third Quarter 2022 Financial Results | Business Wire
Puma Biotechnology, Inc.'s (NASDAQ:PBYI) US$24m market value fall may be overlooked by institutional investors after a year of 1.6% returns - Simply Wall St News